glp-1 safety and side effects Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, effects, risks Weight Loss Pills: Myths, Facts

We created a propensity score to match GLP1-RA users and DDP4i users at a ratio of 1:1 using 120 characteristics selected a priori (listed in Table 1), Variables included: age, gender (self-reported), race and ethnicity (self-reported), demographics, personal history, vital signs, comorbidities, comorbidity and cardiovascular scores, frailty score, healthcare utilization, laboratory values, glucose-lowering medication classes, and other medication classes

Join the ConfectioneryNews Reformulating for healthy indulgence webinar on 23 September 2025.

These small steps increase the payoff from your plan

Key symptoms to monitor include: Tracking these symptoms can provide valuable insights

[DOI] [PubMed] [Google Scholar] Heusch G, Boengler K, Schulz R

AT expansion in obesity triggers immune cell infiltration and cytokine dysregulation, establishing a proinflammatory microenvironment that perpetuates metabolic dysfunction [185]